Mr. Jim Hutchens reports
IMAGIN MEDICAL ANNOUNCES UPLISTING TO OTCQB
Imagin Medical Inc.'s common shares were approved for uplisting from the Pink Open Market to the OTCQB Venture Market, effective June 28, 2018.
"Uplisting to OTCQB is an important milestone in our evolution as a public company," commented Jim Hutchens, Imagin's president and chief executive officer. "We believe this should help with our continuing efforts to broaden our exposure within the investment community, diversify our shareholder base and improve the trading liquidity of our shares."
The OTCQB is a venture market designed for early-stage and developing United States and international companies. To be eligible, companies must be current in their reporting and undergo an annual verification and management certification process.
About Imagin Medical
Inc.
Imagin Medical is developing imaging solutions for the early detection of cancer during minimally invasive surgeries. The company believes it will radically improve the way physicians detect cancer. Imagin's initial target market is bladder cancer, a major cancer worldwide, the sixth-most prevalent in the United States, and the most costly cancer to treat due to a greater-than-50-per-cent recurrence rate. Developed at the Lawrence Livermore National Laboratory, this advanced, ultrasensitive imaging technology is based upon improved optical designs and advanced light sensors.
We seek Safe Harbor.
© 2024 Canjex Publishing Ltd. All rights reserved.